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Illness can take life to the very edge of the abyss, where suffering and death threaten 
the beauty and worth of a person, where the myth of control is realized, where sadness and 
ambiguity replace creativity and love, where time is running out…here angst about existential 
issues challenges our humanity. As Tolstoy wrote, “At one moment a gleam of hope, the next 
a raging sea of despair, and always pain, always misery and pain, over and over again. All this 
lonely misery was terrible” (p.146, The Death of Ivan Ilyich). Tolstoy describes Ilyich as 
trapped by his progressive illness, struggling and writhing in a “black sack” from which there 
was no escape, aware that every moment, “he was drawing nearer and nearer to what terrified 
him” (p.159). 
Although existential suffering in the context of life-threatening illness has long been 
called to attention 1–3, only recently have researchers studied this phenomenon more 
rigorously. Common to this proliferating body of literature is the conceptualization of 
existential distress as a distinct, painful psychological state, that 4–9 
• results from a stressor that challenges fundamental expectations about security, 
interrelatedness with others, justness, controllability, certainty and hope for a long and 
fruitful life; 
• brings a flood of distressing emotions including fear, outrage and horror at the possibility 
of death; concern about autonomy, suffering, or being a burden to others; a sense of 
profound loneliness, pointlessness or hopelessness; grief, regret or embitterment about 
what has been missed in life; and shame if dignity is lost, doubt and disbelief prevail, or 
expectations about coping are not met; 
• has been operationalized by the constructs of fear of cancer recurrence, death anxiety, 
demoralization, dignity-related distress, hopelessness, spiritual distress, and the desire for 
hastened death, which include the aforementioned facets in varying combination and 
emphasis;  
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• fluctuates and occurs on a continuum of severity, where severe and enduring levels are 
clinically significant and maladaptive in a noteworthy subgroup;  
• may occur co-morbidly with other psychiatric disorders but also in their absence, when 
physical pain is well treated, social support is available, and the person has been perceived 
as robust; and finally 
• has a significant impact on health care outcomes. 
Two meta-analyses featured in this issue 10,11 illustrate the progress of the last decade. Yet 
there is much uncertainty about how to recognize and address existential distress in cancer 
care. Much remains to be learned about this crucial state of mind. This special issue brings 
together different lines of current research in the hope of deepening our understanding of this 
phenomenon. We begin by posing a set conceptual and practical questions, reviewing what is 
known, and identifying what needs to be addressed to move the field forward. 
 
How does existential distress arise?  
That distress and suffering, but also growth and mastery may arise from confrontation with 
existential threat is a long-standing idea. Long ago, Jaspers 12 identified that a life-threatening 
disease created a limit situation. Although they are givens of our human nature, the finitude of 
life, any restriction to freedom, reduction of meaning, or isolation from others are thoroughly 
unwelcome yet inescapable eventualities. Cancer brings such losses through a shortened 
lifespan, prognostic uncertainty, altered relationships, and impaired physical functioning, 
autonomy and controllability 6,13,14. When personal beliefs and goals are disrupted, individuals 
may renegotiate what is meaningful 15. Notwithstanding this, Salander highlights how illness 
interferes with the ability to continue a daily routine that provided security and sense of 
purpose, masking the limits of our human existence 16. The idea that attaching to normality 
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can be a source of adjustment fits well with Folkman’s 17 observation that “infusing ordinary 
events with meaning” helps ameliorate stress and uncertainty. 
Fear of cancer recurrence has been one recent focus of inquiry 18. A recent integrative 
model identified threat of loss and death, ongoing uncertainty and limited control, and 
ongoing reminders of cancer are relevant sources of anxiety for all patients with cancer 19. 
Advanced cancer brings fear of the process of dying, its consequences for close others, regret 
about not having reached important goals and being a burden, well exemplified by studies 
using the Death and Dying Distress Scale (DADDS) and the Patient Dignity Inventory (PDI) 
20,21. Similar fears underlie the fear of recurrence in cancer survivors. Death anxiety has many 
presentations and ways of being masked 22. For death anxiety and fear of cancer recurrence 
alike, both very low levels (over-avoidance) and very high levels (over-rumination, excessive 
worry) have been found to be maladaptive 23. A better understanding of the dynamics of how 
individuals approach versus deflect from existential threat would be of value to psycho-
oncology interventions 24. A renewed interest in cognitive-existential interventions for fear of 
cancer recurrence supports this direction 18,25. 
An et al. in this issue 26 show for the first time a close link between death anxiety as 
assessed by the DADDS and demoralization. The latter is characterized by feeling trapped 
and helpless, of having failed one’s own or others’ expectations, and that life is pointless 
looking forwards 27. A prospective analysis could extend An et al.’s 26 findings that the loss of 
morale may underlie death anxiety and show how both states develop over time.   
Interested in why and how individuals experience different patterns of existential 
distress when confronted with cancer, Lo 28 applies Erikson’s formulation of developmental 
conflicts. Existential themes are organized in layers that can be activated differentially by 
severe illness. Firstly, illness can interfere with individuals’ intrapersonal “solutions” for 
specific developmental challenges – higher existential distress may result, for example, when 
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a person’s sense of identity is closely linked to physical appearance and functioning (see 
Bickford et al. 29 for an illustration). Such struggle may become even more challenging in 
advanced disease, when a shortened life expectancy limits generativity and prompts life 
review. Masterson and colleagues 30 showed that 72% of patients with advanced cancer 
reported at least one aspect of unfinished business, with over half of these responses being 
related to family, relationships and realization of personally meaningful activities. Lo’s 28 
developmental perspective highlights how what is of meaning and value in life may be closely 
linked to the individual pattern of personal losses and changes.  
Authors disagree about the relationship between existential and spiritual distress. 
Some understand spiritual distress as linked to a crisis in belief or loss of connection to a 
higher being 31. Others do not see themselves as spiritual or religious, and prefer the concept 
of existential distress 16. A practical approach could be to understand spiritual distress as one 
aspect of existential distress 7. 
 
Who is at risk for and what helps existential distress? 
Regarding demographic and disease-related risk factors, a similar mixed pattern of findings 
has emerged for existential as for cancer-related distress in general. Women, those who are 
single, carry a higher symptom burden and receive less support report higher existential 
distress 32, 33. Complex interactions of these factors may underlie the mixed findings across 
different cancer populations.   
Looking deeper, we may ask “What is helpful about perceived positive social support in the 
context of uncertainty?” Soriano et al. 34 studied couples’ responses to uncertainty, where the 
need for connectedness was high, yet not always sufficient to assuage existential treat. Health 
care providers were found to bolster support through person-centered care, instilling trust 
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through shared decision-making, and thus lowering demoralization in patients with advanced 
cancer 35, 36.   
Similarly, “what coping strategies ameliorate fear of recurrence?” Patients with a high 
intolerance of uncertainty and positive metacognitive beliefs about worry seem at a higher 
risk to engage in maladaptive behavioral processes such as avoidance, checking behaviors, 
and seeking constant reassurance from physicians 37. However, patients do not adopt the same 
coping responses, exemplified by Galica et al. 38 who found that the dimensions of the Fear of 
Cancer Recurrence Inventory (FCRI) did not load on a single second-order factor, indicating 
that the subscales, including coping strategies, should not be combined into a total fear of 
cancer recurrence score.  
Taken together, we observe that the study of adjustment to existential challenge is in 
its relative infancy. Progress will likely occur with richer etiological models and application 
of sophisticated methods such as within-person analyses 34 that test hypotheses about 
individual adaptation mechanisms. 
 
What is the threshold for clinically relevant existential distress? 
There is no current consensus about the criteria that signify the clinical threshold at which 
existential distress ought to be deemed pathological. However, efforts to approach a definition 
are underway. A recent Delphi study suggested that fear of cancer recurrence be considered 
clinically problematic when (1) preoccupation with thoughts of recurrence or progression 
cause intense distress; (2) unhelpful coping strategies are adopted; (3) daily functioning is 
impaired; and (4) there is limited ability to plan for the future 39. Similarly, studies using 
interview criteria from the Diagnostic Criteria for Psychosomatic Research–Demoralization 40 
report a very close association with scores on the Demoralization Scale.  This is coherent with 
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demoralization being pathological when: (1) over a period of two or more weeks, (2) 
difficulty in coping with a stressor occurs, causing the person to feel trapped, helpless and 
unable to control or change the predicament; (3) a sense of failure results in meeting the 
expectations of self or others; and (4) a resultant sense of aloneness, hopelessness, or 
pointlessness develops due to lack of a worthwhile future. 41 
The interesting overlaps between these definitions suggest that their conceptual 
integration could be worthwhile. One idea that would resonate well with its stressor-bound 
nature is to think of clinically elevated existential distress as an adjustment disorder, although 
criteria for the latter diagnosis have been vague and based on the clinician’s judgement. The 
difficulty to cope, perceived incompetence to plan for the future, and impaired function with 
significant distress are common attributes that align with current specifications of adjustment 
disorder in DSM and ICD. This perspective would not understand existential distress-
adjustment disorder as a “subthreshold problem” (hierarchically only diagnosed when criteria 
for depressive or anxiety disorders are not fully met), but a distinct entity that can be related 
to intense suffering. It is also coherent with the findings of Bobevski et al. 42, indicating a 
distinct and significant subgroup (13%) with moderate demoralization, significant functional 
impairment and increased risk for suicidal ideation. Two dominant symptom clusters of 
adjustment difficulty could exist: a) worried preoccupation with what could happen in an 
excessive attempt to control, and b) the disheartened despair about what cannot happen.  
 
How frequent is existential distress in patients with cancer? 
In the absence of consensus-based assessment standards, only preliminary data are available. 
Nanni and colleagues 40 have found a frequency of 25% using the DCPR interview for 
demoralization, similar to one systematic review 43, whereas others have found a lower 
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prevalence of clinically significant demoralization in the 13-18% range 33. Fear of recurrence 
is also high: a systematic review reported a prevalence of 49% using various criteria and 
instruments 32. Using the brief 6-item Cancer Worry Scale, Custers et al. 44 found that half 
suffered from this distress, while using the Patient Dignity Inventory, Bovero et al. 45 reported 
one fifth distressed.  
  
The co-morbidity of existential distress with anxiety and depression? 
The clinical utility of the concept of existential distress is its differentiation from other forms 
of distress, although some co-morbidity with other psychiatric disorders is inevitable. 
Existential distress has been distinguished from depression because a lack of pleasure and 
lowered mood need not be present, and from anxiety disorders because the explicit focus is on 
a life-threatening disease 49,50. Empirically, high levels of fear of recurrence were present in 
13% of patients in the absence of an anxiety disorder 51, and high levels of demoralization in 
14% in the absence of anxiety or mood disorders 52. Also, symptom classification studies 
point towards a differentiation of anhedonia and demoralization 53. Applying latent class 
differentiation, Bobevski et al. 42 found that demoralization was present in two groups, where 
one had severe symptoms of anxiety and depression with high levels of demoralization (10%) 
and the second was characterized by moderate demoralization and low anxiety and depression 
(13%). These results are coherent with the idea that demoralization can occur independently, 
but also as a result of high levels of depression and anxiety. Self-report measures of 
existential distress have all demonstrated moderate to high correlations with those of 
depression and anxiety, typically ranging from 0.33 to 0.7252, comparable to the size of 
correlations between self-reported anxiety and depression.  
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The observation that many essential characteristics of existential distress are not 
adequately covered by current psychiatric nosology is supported by the significant subgroups 
of patients with moderate to high existential distress but no mental disorder. We are not 
pathologizing normal human experience, as some existential distress is surely part of our 
humanity, but rather searching for diagnostic categories that help to recognize severe and 
maladaptive existential states, thus empowering these patients to receive appropriate 
treatments. 
 
Unrecognized existential distress mars health care outcomes 
One important rationale behind the study of existential distress is that its management can 
reduce the risk for suicidal ideation, mental disorders, nonadherence to treatment, and low 
quality of death and dying. Fear of cancer recurrence has been related to lower quality of life, 
reduced functioning and problematic health behaviors 32 and demoralization showed an 
independent impact on suicidal ideation beyond mood and anxiety disorders 52.  
When studying the relationship between existential distress and health outcomes, especially 
quality of life, researchers need to be aware of a potential item overlap between instruments. 
To the extent that existential distress measures include items that refer to well-being or its 
lack, it will not be surprising that they correlate closely with quality of life 16. While some 
overlap with outcome measures may be unavoidable, studies should use existential distress 
measures based on a clear theoretical framework. The aim is to test prospectively their 
potential unique predictive impact on health care-relevant outcomes, while controlling for 
established factors such as anxiety, depression, and physical symptom burden. 
 
How do we ameliorate existential distress? 
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Interventions to relieve existential pain have received much less attention than those for 
anxiety and depression. The two meta-analyses featured in this issue reflect substantial 
progress since the review by LeMay & Wilson in 2008 9. Bauereiß et al. 10 have identified 30 
RCTs testing existential therapies in predominantly advanced cancer patients, including trials 
of Supportive-Expressive Group Therapy, Cognitive-Existential Group Therapy, Dignity 
Therapy, Meaning-Centered Psychotherapy, Managing Cancer and Living Meaningfully 
(CALM) Therapy, and the Life Review, Narrative, Hope and Meaning-Making Intervention. 
While significant small to moderate pooled effects on post-treatment quality of life and 
existential well-being have emerged for existential therapies over control conditions, effects 
on anxiety and depression were significant only after exclusion of four studies with baseline 
group differences suggesting randomization difficulties. Two recent large trials with 
significant small effects on depression 54, 55 were published after this analysis. All told, clear 
benefits arise from existentially-oriented psychotherapy.  
Looking specifically at fear of cancer recurrence, Hall et al. 11 identified 19 studies of 
the efficacy of cognitive-behavioral, relaxation, mindfulness and mixed mind-body 
interventions. They found small to medium effects compared to control conditions that were 
not moderated by type of treatment. Esplen et al. 59 tested the efficacy of Supportive-
Expressive Group Therapy (SEGT) for women with hereditary breast cancer, where fear of 
the future development if cancer is targeted. While most interventions included 6 or more 
sessions, Davidson et al. 56 proposed that a single session which was CBT- and telephone-
based in approach could help to alleviate fear of cancer recurrence. Future work may build on 
what has been learned from earlier cognitive-existential approaches 25 and integrate CBT-
skills with death anxiety interventions 57. The techniques used in effective interventions for 
existential concerns are heterogeneous: shared identification of meaningful activity and 
priorities, review of strengths, accomplishments, the life story including missed opportunities 
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or regrets, crafting a legacy document, open exploration of losses and death-related fears, 
support for uncertainty, and mentalizing death to understand and achieve a sense of mastery 
over what the future might hold.  More study of the process of therapy and what induces 
change is needed. 
The rareness of suicide has led to few prevention studies, yet the international take-up 
of medically assisted dying creates an opportunity to see if psychotherapeutic interventions 
can prevent the premature ending of life based on fear of the future and demoralization. 
Banyasz et al. 58 suggest that an existential perspective can substantially improve 
understanding and relieve suicidal ideation. And of course, attention to caregivers and their 
needs offer relief for dying patients and should always be part of existentially-oriented work 
60.  
 
Suggestions for future research  
The contributions featured in this special issue reflect the current state of the art with its 
emerging maturity, while opening up many questions at the same time. Much more 
integration is needed in these studies. We believe that the link between existential stressors, 
adjustment processes and existential distress patterns needs further inquiry. 
Clearly, a threshold for what characterizes clinically relevant existential distress needs 
to be established. The high correlation between existential distress constructs suggests that 
greater consensus is possible about diagnostic categories, which would, in turn, lead to better 
recognition and treatment. Such studies should be longitudinal and include diverse 
populations of cancer patients to enable more generalizable conclusions about the relevance 
of existential distress. 
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There are topics that have received less attention in this special issue. Although 
relational aspects were relevant to some studies, existential loneliness, which can result from 
cancer’s challenges to intimacy was not studied in detail. Related experiences of not feeling 
connected, that no one can help, or that important things have been left unsaid are featured in 
several existential distress measures, but more specific data on these aspects are lacking. 
Furthermore, only two studies incorporated the caregiver perspective. Caregivers may 
experience their own existential challenges as they observe the suffering and anticipate the 
loss of their loved one 61. Little is known about the occurrence and relevance of existential 
distress in caregivers of cancer patients. Moreover, cultural differences in the expression of 
existential needs are not well understood. Although existential concerns are universal, culture 
and heath care systems can influence different expressions. 
Conversations about existential questions can be challenging. They may activate a 
clinician’s own death anxiety or identification with a patient’s loss of morale. Yet perhaps the 
lack of knowledge about the nature of existential distress and how it can be managed are the 
most relevant barriers to any clinician’s sense of self-efficacy in dealing with existential 
themes. We hope that this special issue may inspire progress in this promising area of inquiry 
to improve cancer care.  
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